These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20192931)

  • 21. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
    Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
    Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
    Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
    Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka.
    Priyadharshana U; Piyasiri LB; Wijesinghe C
    Ceylon Med J; 2019 Dec; 64(4):140-145. PubMed ID: 32120467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
    Søgaard M; Heide-Jørgensen U; Vandenbroucke JP; Schønheyder HC; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2017 Dec; 23(12):952-960. PubMed ID: 28377310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.
    Colodner R; Kometiani I; Chazan B; Raz R
    Infection; 2008 Feb; 36(1):41-5. PubMed ID: 18193386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.
    Larramendy S; Gaultier A; Fournier JP; Caillon J; Moret L; Beaudeau F
    J Antimicrob Chemother; 2021 Feb; 76(3):789-795. PubMed ID: 33351903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B; Gebre-Selassie S; Feleke Y
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
    Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
    J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
    Fasugba O; Gardner A; Mitchell BG; Mnatzaganian G
    BMC Infect Dis; 2015 Nov; 15():545. PubMed ID: 26607324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnosis and therapy of first community acquired urinary tract infection in children].
    Miron D; Grossman Z
    Harefuah; 2009 Nov; 148(11):778-82, 792, 791. PubMed ID: 20027983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital.
    Fleming VH; White BP; Southwood R
    Am J Emerg Med; 2014 Aug; 32(8):864-70. PubMed ID: 24877721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
    Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
    Wang SS; Ratliff PD; Judd WR
    Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
    Michno M; Sydor A; Wałaszek M; Sułowicz W
    Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Bacterial Spectrum and Antimicrobial Susceptibility in Female Recurrent Urinary Tract Infection: How Different They Are From Sporadic Single Episodes?
    Hisano M; Bruschini H; Nicodemo AC; Gomes CM; Lucon M; Srougi M
    Urology; 2015 Sep; 86(3):492-7. PubMed ID: 26163810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Empirical Antimicrobial Therapy for Pediatric Community-onset Febrile Urinary Tract Infection in the Era of Increasing Antimicrobial Resistance.
    Kantamalee W; Santanirand P; Saisawat P; Boonsathorn S; Techasaensiri C; Apiwattanakul N
    Pediatr Infect Dis J; 2020 Feb; 39(2):121-126. PubMed ID: 31738320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic Overconsumption in Pregnant Women With Urinary Tract Symptoms in Uganda.
    Sekikubo M; Hedman K; Mirembe F; Brauner A
    Clin Infect Dis; 2017 Aug; 65(4):544-550. PubMed ID: 29017265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.